Antidepressants for children: Is scientific support necessary?

Journal of Nervous and Mental Disease

Volumn 184, Issue 2, 1996, Pages 99-102

  Fisher, Rhoda L ^b   Fisher, Seymour ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CHILD; CHILD PSYCHIATRY; DEPRESSION; HUMAN; SHORT SURVEY;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; CHILD; CHILD PSYCHIATRY; CLINICAL TRIALS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; ETHICS, MEDICAL; HUMANS; PEDIATRICS; PLACEBO EFFECT; TREATMENT OUTCOME;

EID: 0029876823     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005053-199602000-00006     Document Type: Short Survey

References (30)

1. Ambrosini PJ, Bianchi MD, Rabinovish H, Ella J (1993) Antidepressant treatments in children and adolescents. I. Affective disorders. J Am Acad Child Adolesc Psychiatry 32:1-5.
2. Banta HD, Thacker SB (1990) The case for reassessment of health care technology: Once is not enough. JAMA 264:235-246.
3. Bishop JM (1984) Infuriating tensions: Science and the medical student. J Med Educ 59:91-102.
4. Boulos C, Kutcher S, Marton P, Simeon J, Ferguson B, Roberts N (1991) Response to desimpramine treatment in adolescent major depression. Psychopharmacol Bull 27:59-65.
5. Conners CK (1992) Methodology of antidepressant drug trials for treating depression in adolescents. J Child Adolesc Psychopharmacol 2:11-22.
6. Elliott GR (1992) Dilemmas for clinicians and researchers using antidepressants to treat adolescents with depression. J Child Adolesc Psychopharmacol 2:7-9.
7. Evidence-Based Medicine Working Group (1992) Evidence-based medicine: A new aproach to teaching the practice of medicine. JAMA 268:2420-2425.
8. Gadow KD (1991) Clinical issues in child and adolescent psychopharmacology. J Consult Clin Psychol 59:842-852.
9. Geller B, Cooper TB, Graham DL, Fetner HH, Marsfeiler FA, Wells J (1992) Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6 to 12 year olds with major depressive disorder. J Am Acad Child Adolesc Psychiatry 31:34-44.
10. Geller B, Cooper TB, Graham DL, Marsfeller FA, Bryant DM (1990) Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 26:85-90.
11. Goleman D (1993, December 15) Use of antidepressants in children at issue. The New York Times, p. 17.
12. Green WH (1991) Child and adolescent clinical psychopharmacology. Baltimore: Williams & Wilkins.
13. Grimes DA (1993) Technology follies: The uncritical acceptance of medical innovation. JAMA 269:3030-3033.
14. Hughes CW, Preskorn SH, Woller E, Woller R, Hassamein R, Tucker S (1990) The effect of concomitant disorders in childhood depression on predicting treatment response. Psychopharmacol Bull 26:235-238.
15. Johnston HF, Fruehling JJ (1994) Pharmacological therapy for depression in children and adolescents. In WM Reynolds, HF Johnston (Eds) Handbook of Depression in Children and Adolescents. New York, Plenum.
16. Kashani JH, Shekim WO, Reid JC (1994) Amitriptyline in children with major depressive disorder: A double-blind crossover pilot study. J Am Acad Child Adolesc Psychiatry 23:348-351.
17. Kramer A, Feiguine R (1981) Clinical effects of amitriptyline in adolescent depression: A double-blind crossover pilot study. J Am Acad Child Adolesc Psychiatry 20:36-44.
18. Kutcher S, Boulos C, Ward B, Marton P (1994) Response to desipramine treatment in adolescent depression: A fixed-dose placebo controlled trial. J Am Acad Child Adolesc Psychiatry 33:686-694.
19. Lucas A, Lockett H, Grimm F (1965) Amitriptyline in childhood depressions. Dis Nerv Syst 26:105-110.
20. Lynoe N (1992) Ethical and professional aspects of practice of alternative medicine. Scand J Soc Med 4:217-225.
21. Pellegrino ED, Thomasma DC (1981) A Philosophical Basis of Medical Practice. New York: Oxford University Press.
22. Petti T, Law W (1982) Imipramine treatment of depressed children: A double-blind pilot study. J Clin Psychopharmacol 2: 107-110.
23. Popper CW (1992) Are clinicians ahead of researchers in finding a treatment for adolescent depression? [Editorial] J Child Adolesc Psychopharmacol. 2:1-3.
24. Preiskorn SH, Weller EB, Hughes C, Weller RA, Bolte K (1987) Depression in prepubertal children: Dexamethasone nonsuppression predicts differential response to imipramine vs. placebo. Psychopharmacol Bull 23:265-268.
25. Puig-Antich J, Perel JM, Lupatkin W, Chambers W, Shea C, Tabrize MA, Stiller R (1979) Plasma levels of imipramine and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorders. J Am Acad Child Adolesc Psychiatry 18:616-627.
26. Puig-Antich J, Perel JM, Lupatkin W, Chambers WJ, Tabrizi MA, King J, Goetz R, Davies M, Stiller RL (1987) Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry 44:81-89.
27. Riddle MA, Geller B, Ryan N (1993) Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 9:283-289.
28. Roy DJ (1986) Ethics in clinical research and clinical practice. Clin Invest Med 9:283-289.
29. Simeon J, DiNicola V, Phil M, Ferguson H, Copping W (1990) Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 14:791-795.
30. Wulff HR (1986) Rational diagnoses and treatment. J Med Philos 11:123-134.